Skip to main content
OpenTrials

Clinical trial condition

Postneoadjuvant Treatment With CDK 4/6 Inhibitor

Explore clinical trials studying Postneoadjuvant Treatment With CDK 4/6 Inhibitor. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies
Refine in advanced search Browse all conditions

Postneoadjuvant Treatment With CDK 4/6 Inhibitor trial results

Completed

A Study of Palbociclib in Addition to Standard Endocrine Treatment in Hormone Receptor Positive Her2 Normal Patients With Residual Disease After Neoadjuvant Chemotherapy and Surgery

NCT01864746

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +8 more
Locations
  • NSABP Foundation Pittsburgh, Pennsylvania, United States
  • Contact: Australia and New Zealand Breast Cancer Trials Group Newcastle, NSW 2310, Australia
  • Contact: Austrian Breast & Colorectal Cancer Study Group Vienna, Austria
  • Contact: NSABP Foundation Multiple Locations, Canada
View Trial Details

Related conditions